Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

GLAND PHARMA LTD.

NSE : GLANDBSE : 543245ISIN CODE : INE068V01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE1890.05-11.3 (-0.59 %)
PREV CLOSE () 1901.35
OPEN PRICE () 1950.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 36724
TODAY'S LOW / HIGH ()1878.70 1950.60
52 WK LOW / HIGH ()1590 2220.95
NSE1890.75-10.35 (-0.54 %)
PREV CLOSE() 1901.10
OPEN PRICE () 1964.00
BID PRICE (QTY) 1890.75 (36)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 443053
TODAY'S LOW / HIGH() 1878.15 1964.00
52 WK LOW / HIGH ()1585.7 2220.95
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1978

Management Info :

Srinivas Sadu - Chairman - Managing Director

Registered Office :

Address : Survey No. 143-148, 150 & 151,Near Gandimaisamma 'x' Roads, D. P. Pally,Dundigal Gandimaisamma Mandal, Medchal- Malkajgiri District,
Hyderabad,
Telangana-500043

Phone : 040 30510999

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
12Dec Gland Pharma gets USFDA’s approval for
Gland Pharma has received approval from the United States Food and Drug..
12Dec Gland Pharma shines on getting USFDA’s
Gland Pharma is currently trading at Rs. 1810.05, up by 34.70 points or..
03Dec Gland Pharma gets USFDA’s nod for Lata
Gland Pharma has received approval from the United States Food and Drug..
03Dec Gland Pharma informs about press relea
Pursuant to Regulation 30 read with Part A of Schedule III of the Securi..
03Dec Gland Pharma jumps on getting USFDA’s
Gland Pharma is currently trading at Rs. 1805.05, up by 25.65 points or..
Financials
in Millions
QTR Sep 24 ANNUAL 24
Net Profit2817.110433.25
Gross Profit 3798.16 14054.97
Operating Profit 4216.0315754.47
Net Sales 10629.941674.28
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 29939.60 (1.58%)
M.Cap ( in Cr)
63619.56
Astrazeneca Pharma I (BSE)
 7251.75 (1.94%)
M.Cap ( in Cr)
18129.38
Ajanta Pharma (BSE)
 2948.80 (2.70%)
M.Cap ( in Cr)
36834.08
Concord Biotech (BSE)
 2158.60 (3.38%)
M.Cap ( in Cr)
22582.45
Alkem Laboratories (BSE)
 5524.45 (0.44%)
M.Cap ( in Cr)
66053.09
Shareholding Pattern
PROMOTERS 51.83%
MUTUAL FUNDS/UTI 32.83%
NON-INSTITUTION 8.32%
FI/BANKS/INSURANCE 1.5%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX77964.99-1258.12 (-1.59%)
NIFTY23616.05-388.70 (-1.62%)
Dow Jones 42732.13339.86 (0.80%)
Nasdaq 19621.68340.89 (1.77%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI